The Janssen Pharmaceutical Companies of Johnson & Johnson’s Post

Janssen is taking on a range of common diseases of the retina, like geographic atrophy (GA). GA is an advanced form of age-related macular degeneration (AMD), and a leading cause of irreversible vision loss. This disease affects over 8 million people worldwide and is a leading cause of blindness in people over 65 years of age worldwide. GA causes central vision loss, making it difficult for patients to accomplish everyday tasks, such as reading, driving, cooking, or even seeing faces. Learn more about our commitment to reduce the patient burden for those living with GA this World Retina Day: https://bit.ly/3ETD1AF #JanssenRetina #GeographicAtrophy #WorldRetinaDay